Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
At close: Jul 29, 2026

IPIX Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '23 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19
Revenue
--0.02-0.42-
Revenue Growth
------
Gross Profit
--0.02-0.42-
Operating Income
-2.36-2.94-6.76-9.02-4.64-6.3
Net Income
-2.62-3.17-7.04-13.87-6.65-8.68
Earnings Per Share
-0.01-0.01-0.01-0.04-0.03-0.05
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '23 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19
Cash & Investments
0.861.523.8110.196.020.58
Total Debt
0.70.731.291.872.462.8
Net Cash (Debt)
0.170.792.528.323.56-2.22
Net Cash Growth
-90.24%-68.52%-69.73%133.63%--
Net Cash Per Share
0.000.000.010.020.01-0.01

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '23 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19
Operating Cash Flow
-1.99-2.11-6.28-9.5-4.16-6.33
Capital Expenditures
------
Free Cash Flow
-1.99-2.11-6.28-9.5-4.16-6.33
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '23 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19
Gross Margin
--100.00%-100.00%-
Operating Margin
---37544.44%--1095.74%-
Pretax Margin
---39116.67%--1571.63%-
Profit Margin
---39116.67%--1571.63%-
FCF Margin
---34888.89%--982.51%-

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19
PS Ratio
--26.94-285.59-